Premium
TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1
Author(s) -
Schultheiss Ute,
Püschner Stephanie,
Kremmer Elisabeth,
Mak Tak W.,
Engelmann Hartmut,
Hammerschmidt Wolfgang,
Kieser Arnd
Publication year - 2001
Publication title -
the embo journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.484
H-Index - 392
eISSN - 1460-2075
pISSN - 0261-4189
DOI - 10.1093/emboj/20.20.5678
Subject(s) - tradd , biology , microbiology and biotechnology , traf2 , signal transduction , mapk/erk pathway , p38 mitogen activated protein kinases , map kinase kinase kinase , protein kinase a , death domain , kinase , cancer research , tumor necrosis factor alpha , immunology , apoptosis , programmed cell death , tumor necrosis factor receptor , biochemistry
The oncogenic latent membrane protein 1 (LMP1) of the Epstein–Barr virus recruits tumor necrosis factor‐receptor (TNFR)‐associated factors (TRAFs), the TNFR‐associated death domain protein (TRADD) and JAK3 to induce intracellular signaling pathways. LMP1 serves as the prototype of a TRADD‐binding receptor that transforms cells but does not induce apoptosis. Here we show that TRAF6 critically mediates LMP1 signaling to p38 mitogen‐activated protein kinase (MAPK) via a MAPK kinase 6‐dependent pathway. In addition, NF‐κB but not c‐Jun N‐terminal kinase 1 (JNK1) induction by LMP1 involves TRAF6. The PxQxT motif of the LMP1 C‐terminal activator region 1 (CTAR1) and tyrosine 384 of CTAR2 together are essential for full p38 MAPK activation and for TRAF6 recruitment to the LMP1 signaling complex. Dominant‐negative TRADD blocks p38 MAPK activation by LMP1. The data suggest that entry of TRAF6 into the LMP1 complex is mediated by TRADD and TRAF2. In TRAF6‐knockout fibroblasts, significant induction of p38 MAPK by LMP1 is dependent on the ectopic expression of TRAF6. We describe a novel role of TRAF6 as an essential signaling mediator of a transforming oncogene, downstream of TRADD and TRAF2.